Indications
Pharmacology
- Atypical Anti-Psychotic Agent
- Serotonin 5-HT3 Receptor Antagonism (ee Serotonin 5-HT3 Receptor Antagonists, [[Serotonin 5-HT3 Receptor Antagonists]])
Administration
- PO: start xxxx
Adverse Effects
Cardiovascular Adverse Effects
- Hypotension/Orthostatic Hypotension (see Hypotension, [[Hypotension]])
Endocrinologic Adverse Effects
- Hyperglycemia (see Hyperglycemia, [[Hyperglycemia]])
- Hyperlipidemia (see Hyperlipidemia, [[Hyperlipidemia]])
- Weight Gain (see Weight Gain, [[Weight Gain]])
Gastrointestinal Adverse Effects
- Acute Pancreatitis (see Acute Pancreatitis, [[Acute Pancreatitis]])
- Hepatotoxicity (see xxxx, [[]])
Hematologic Adverse Effects
- Anemia (see Anemia, [[Anemia]])
- Leukopenia/Neutropenia (see Leukopenia, [[Leukopenia]] and Neutropenia, [[Neutropenia]])
- Thrombocytopenia (see Thrombocytopenia, [[Thrombocytopenia]])
Neurologic Adverse Effects
- Extrapyramidal Symptoms (see xxxx, [[]])
- Neuroleptic Malignant Syndrome (see Neuroleptic Malignant Syndrome, [[Neuroleptic Malignant Syndrome]])
Renal Adverse Effects
- Acute Kidney Injury (AKI) (see Acute Kidney Injury, [[Acute Kidney Injury]])
Rheumatologic/Orthopedic Adverse Effects
- Rhabdomyolysis (see Rhabdomyolysis, [[Rhabdomyolysis]])
Other Adverse Effects
- Xxxx
- Xxxx
- Xxxx
- Xxxx
References
- Atypical Antipsychotic Drugs and the Risk for Acute Kidney Injury and Other Adverse Outcomes in Older Adults: A Population-Based Cohort Study. Ann Intern Med. 2014;161(4):242-248. doi:10.7326/M13-2796